|
|
 Previous Article | Table of Contents | Next Article 
Allelotype Analysis in the Evolution of Chronic Myelocytic Leukemia
Naoki Mori,
Roberta Morosetti,
Stephen Lee,
Susanne Spira,
Dina Ben-Yehuda,
Gary Schiller,
Raffaele Landolfi,
Hideaki Mizoguchi, and
H. Phillip Koeffler
From the Department of Medicine and Department of Clinical Pathology, Cedars-Sinai Medical Center, UCLA School of Medicine, Los Angeles, CA; Hemostasis Research Center, Catholic University of Rome, Italy; the Department of Hematology, Hadassah Medical Organization, Jerusalem, Israel; the Department of Hematology/Oncology, UCLA School of Medicine, Los Angeles, CA; and the Department of Hematology, Tokyo Women's Medical College, Japan.
To elucidate the genetic events that may play important roles in the progression of chronic myelocytic leukemia (CML), we performed allelotype analysis in 30 patients with CML as the disease transformed to accelerated phase or blast crisis (21 myeloid and 9 lymphoid cases). DNAs were extracted from slides of bone marrow smears or from freshly isolated bone marrow mononuclear cells. The DNAs from the same individuals in both chronic phase and either blast crisis or accelerated phase were analyzed at 82 microsatellite markers, which mapped to each of the autosomal arms except the short arms of the acrocentric chromosomes. Loss of heterozygosity (LOH) on at least one locus was observed in 21 of the 30 cases (70%) as the disease progressed. Frequent allelic loss of  20% of the informative cases was observed on chromosome arms 1p (35%), 7p (21%), 19p (20%), and 20q (29%). Allelic losses were also analyzed according to phenotypes. LOH of 20% was detected on 1p (29%), 18p (20%), and 20q (27%) in myeloid blast crisis, and on 1p (50%), 4p (25%), 7p (43%), 9p (29%), 18q (25%), 19p (43%), and 20q (33%) in lymphoid blast crisis. Serial cytogenetic information was available for most of our cases with LOH on these arms, and only one case had loss of both chromosomes 9 and 20. Fractional allelic loss, calculated for each sample as the total number of chromosomal arms lost/total number of arms with information, showed a median value of 0.06 and a mean of 0.098 (range 0 to 0.60). These results suggest that tumor suppressor genes especially on 1p, 7p, 19p, and 20q probably have an important role in the progression to blast crisis of CML.
Blood, Vol. 90 No. 5 (September 1), 1997:
pp. 2010-2014
© 1997 by The American Society of Hematology.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati What's this?
This article has been cited by other articles:
|
|
|
|
 
P. J. Campbell, E. J. Baxter, P. A. Beer, L. M. Scott, A. J. Bench, B. J. P. Huntly, W. N. Erber, R. Kusec, T. S. Larsen, S. Giraudier, et al.
Mutation of JAK2 in the myeloproliferative disorders: timing, clonality studies, cytogenetic associations, and role in leukemic transformation
Blood,
November 15, 2006;
108(10):
3548 - 3555.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Tavor, D. J. Park, S. Gery, P. T. Vuong, A. F. Gombart, and H. P. Koeffler
Restoration of C/EBP{alpha} Expression in a BCR-ABL+ Cell Line Induces Terminal Granulocytic Differentiation
J. Biol. Chem.,
December 26, 2003;
278(52):
52651 - 52659.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. Mei, P. C. Galipeau, C. Prass, A. Berno, G. Ghandour, N. Patil, R. K. Wolff, M. S. Chee, B. J. Reid, and D. J. Lockhart
Genome-wide Detection of Allelic Imbalance Using Human SNPs and High-density DNA Arrays
Genome Res.,
August 1, 2000;
10(8):
1126 - 1137.
[Abstract]
[Full Text]
|
|
|
|
|
|
|
N. Mori, R. Morosetti, E. Hoflehner, M. Lubbert, H. Mizoguchi, and H. P. Koeffler
Allelic Loss in the Progression of Myelodysplastic Syndrome
Cancer Res.,
June 1, 2000;
60(11):
3039 - 3042.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
I. N. Rich, D. Worthington-White, O. A. Garden, and P. Musk
Apoptosis of leukemic cells accompanies reduction in intracellular pH after targeted inhibition of the Na+/H+ exchanger
Blood,
February 15, 2000;
95(4):
1427 - 1434.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. B. Sinclair, E. P. Nacheva, M. Leversha, N. Telford, J. Chang, A. Reid, A. Bench, K. Champion, B. Huntly, and A. R. Green
Large deletions at the t(9;22) breakpoint are common and may identify a poor-prognosis subgroup of patients with chronic myeloid leukemia
Blood,
February 1, 2000;
95(3):
738 - 743.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
N. Mori, R. Morosetti, S. Spira, S. Lee, D. Ben-Yehuda, G. Schiller, R. Landolfi, H. Mizoguchi, and H. P. Koeffler
Chromosome Band 1p36 Contains a Putative Tumor Suppressor Gene Important in the Evolution of Chronic Myelocytic Leukemia
Blood,
November 1, 1998;
92(9):
3405 - 3409.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Y. Hatta, Y. Yamada, M. Tomonaga, J. W. Said, I. Miyosi, and H. P. Koeffler
Allelotype Analysis of Adult T-Cell Leukemia
Blood,
September 15, 1998;
92(6):
2113 - 2117.
[Abstract]
[Full Text]
[PDF]
|
|
|
| |
